https://doi.org/10.4081/vl.2014.1933

Ultrasound-guided sclerotherapy using liquid sclerosant after preliminary saline flush

Vol. 3 (2014)
Submitted: 20 September 2013
Accepted: 16 January 2014
Published: 17 March 2014
sclerotherapy, saline flush, liquid sclerosant.
Abstract Views: 1109
PDF: 882
HTML: 326
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Kenneth A. Myers
myers.kaba@gmail.com
Victoria Vein Clinic, Melbourne, Australia.
Amy May Clough
Victoria Vein Clinic, Melbourne, Australia.
The aim of this study is to evaluate the efficacy of liquid sclerosant with preliminary saline flush for ultrasound-guided sclerotherapy. Aethoxysklerol was used in varying concentrations ranging from 1.0% to 3.0% according to the volume required. Infusion of sclerosant was preceded by infusion of normal saline. Occlusion rates were determined by life-table analysis. Progressively lower concentrations were used as the study progressed. Life-table analysis showed significantly better results for tributaries compared to saphenous veins (92% vs 65%) and for dilute concentrations (≤1.5%) compared with stronger concentrations (>1.5%) (88% vs 66%). This observational study suggests that liquid sclerosant following a preliminary saline flush may give comparable results to those obtained with foam sclerotherapy. Confirmation would require a randomized controlled trial.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

How to Cite

Myers, K. A., & Clough, A. M. (2014). Ultrasound-guided sclerotherapy using liquid sclerosant after preliminary saline flush. Veins and Lymphatics, 3(1). https://doi.org/10.4081/vl.2014.1933

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.